Adamas Pharmaceuticals reported 3.43M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 7.12M 0.22M
Biocryst Pharmaceuticals BCRX:US $ 13.5M 0.59M
Flexion Therapeutics FLXN:US $ 5.18M 9K
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Novartis NOVN:VX 201M 1000K
Omeros OMER:US $ 4.91M 13K
Revance Therapeutics RVNC:US $ 1.57M 9K
Teva Pharmaceutical TEVA:IT 240M 1000K
Zogenix ZGNX:US $ 3.79M 0.05M